Innate PharmaIPH 
$1.99-0.72%24h
-0.72%24h
Global rank17470
Market cap$160.85M
Change 7d17.94%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Innate Pharma (IPH)
As of January 2025, Innate Pharma has a market cap of $160.85M. This makes Innate Pharma the world's 17470th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innate Pharma from 2006 to 2024
-
Value:-
Market cap history of Innate Pharma from 2006 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $193.52M | -11.83% |
| 2023 | $219.49M | -20.36% |
| 2022 | $275.62M | -26.03% |
| 2021 | $372.63M | 28.48% |
| 2020 | $290.02M | -41.91% |
| 2019 | $499.29M | -19.84% |
| 2018 | $622.86M | 56.53% |
| 2017 | $397.93M | -67.49% |
| 2016 | $1.22B | 6.25% |
| 2015 | $1.15B | 74.05% |
| 2014 | $661.81M | 59.27% |
| 2013 | $415.52M | 130.70% |
| 2012 | $180.11M | 56.93% |
| 2011 | $114.77M | 17.09% |
| 2010 | $98.02M | -51.45% |
| 2009 | $201.89M | 74.64% |
| 2008 | $115.61M | -62.19% |
| 2007 | $305.77M | -41.60% |
| 2006 | $523.59M | - |
IPH Market Cap Today is $160.85M -0.72% - 19 Jan 2025
View largest stocks by market cap 
